COMPASS THERAPEUTICS, INC. (CMPX) Free cash flow 2019–2025
COMPASS THERAPEUTICS, INC. (CMPX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$49.2MFY2025 · since FY2019: -$498,106 → -$49.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.2M | -9.5% |
| FY2024 | -$44.9M | -10.5% |
| FY2023 | -$40.6M | -18.4% |
| FY2022 | -$34.3M | -61.7% |
| FY2021 | -$21.2M | +21.1% |
| FY2020 | -$26.9M | -5302.3% |
| FY2019 | -$498,106 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CMPX financial trends
CMPX RevenueCMPX Net incomeCMPX Net marginCMPX Gross profitCMPX Gross marginCMPX Operating incomeCMPX Operating marginCMPX Operating cash flowCMPX Capital expendituresCMPX Return on equityCMPX Stock buybacksCMPX Dividends paidCMPX Total assetsCMPX Total liabilitiesCMPX Shareholders’ equityCMPX overview →